Aldesleukin

Aldesleukin

(al-des-LOO-kin)

Trade name: Proleukin®
Other names: Interleukin-2, IL-2

Proleukin is the trade name for the generic drug name Aldesleukin. Interleukin-2 and IL-2 are other names for Aldesleukin. In some cases, health care professionals may use the trade name Proleukin or other names Interleukin-2 and IL-2 when referring to the generic drug name Aldesleukin.

Drug type: Aldesleukin is a "biologic response modifier." Aldesleukin is classified as a "cytokine." (For more detail, see "How this drug works" section below).

What Aldesleukin is used for:

Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it may be helpful.

How Aldesleukin is given:
Aldesleukin has been approved for cancer treatment with a high-dose regimen, but it may also be administered in a low-dose form. The high-dose regimen involves giving the drug intravenously (into a vein) every eight hours, as tolerated, for up to 15 doses. There are significant side effects with this regimen (though they are reversible once treatment is stopped). Because of the severity of these side effects, patients are hospitalized and sometimes need intensive care unit support while the drug is being given.

In order to lessen these side effects, an alternate, low-dose regimen was developed. "Low-dose interleukin-2" is administered on an outpatient basis. Low-dose interleukin-2 is usually given as a shot under the skin (subcutaneous injection, SubQ). In some situations, patients may be able to give themselves these injections at home.

Side effects of Aldesleukin:
Important things to remember about the side effects of aldesleukin:

The following are common (occurring in greater than 30%) side effects for patients taking Aldesleukin:

The following are less common (occurring in 10 to 29%) side effects for patients taking Aldesleukin:

A serious, but very uncommon side effect of aldesleukin in high doses is "capillary leak syndrome" or "vascular leak syndrome." Capillary leak syndrome is a potentially serious disease in which fluids within the vascular system (veins and capillaries) leaks into the tissue outside the bloodstream. This results in low blood pressure and poor blood flow to the internal organs. Capillary leak syndrome is characterized by the presence of 2 or more of the following 3 symptoms; low blood pressure, swelling, and low levels of protein in the blood. Your doctor will monitor these things carefully while you are taking aldesleukin. You should notify your doctor immediately if you notice dizziness (especially when changing position), sudden swelling or rapid weight gain, little or no urine output (for 8-12 hours), shortness of breath, difficulty breathing, irregular heart beats, or chest pain.

Not all side effects are listed above, some that are rare (occurring in less than 10% of patients) are not listed here. However, you should always inform your health care provider if you experience any unusual symptoms.

When to contact your doctor or health care provider:

Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:

The following symptoms require medical attention, but are not an emergency. Contact your health care provider within 24 hours of noticing any of the following:

In addition, call your health care provider if any side effects become continuous, serious or your condition worsens.

Precautions:

Self-care tips:

Monitoring and testing:

Before starting treatment with aldesleukin, your doctor will perform a physical exam. Blood tests and often-other types of tests, as decided by your doctor, will be used to evaluate the function of your major organs (heart, lungs, kidneys and liver). Throughout your therapy, your doctor will see you regularly to assess any changes in your blood pressure, weight and level of fatigue, and to discuss side effects. The doctor will order blood tests and other tests as needed to monitor side effects and check your response to therapy.

How Aldesleukin works:

Aldesleukin is classified as a "biologic response modifier (BRM)" or "biologic therapy." BRMs modify the body's response to cancer cells. Interleukin-2 is part of a family of proteins called cytokines. Cytokines act primarily by communicating between the various cells of the body's immune system.

Aldesleukin helps increase production of several different components of the immune system found in the blood, including T lymphocytes and natural killer cells. It also may improve the function of other immune system cells, such as lymphokine-activated killer cells and tumor-infiltrating lymphocytes. This helps the body fight cancer.

Aldesleukin is a synthetic form of interleukin-2, a protein that the body produces naturally. Interleukin-2 was discovered more than 20 years ago. The U.S. Food and Drug Administration approved it in its synthetic form for treatment against cancer in 1992.

Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.